chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Headache, Hyposmia, Musculoskeletal stiffness
Clinical narrative: diarrhea; massive headache; weakness; shortness of breath; chest pain; chest pressure; cough; tested positive for Covid; hyposmia; postnasal drip; stiffness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia) and DIARRHOEA (diarrhea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2020, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and MUSCULOSKELETAL STIFFNESS (stiffness). On 30-Dec-2020, the patient experienced HYPOSMIA (hyposmia). On 31-Dec-2020, the patient experienced COVID-19 (tested positive for Covid), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and COUGH (cough). At the time of the report, COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain) and COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications include Sudafed, Tylenol, zinc , vitamin c, Z-pak and inhaler. No concomitant medications were provided by reporter.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: diarrhea; massive headache; weakness; shortness of breath; chest pain; chest pressure; cough; tested positive for Covid; hyposmia; postnasal drip; stiffness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia) and DIARRHOEA (diarrhea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2020, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and MUSCULOSKELETAL STIFFNESS (stiffness). On 30-Dec-2020, the patient experienced HYPOSMIA (hyposmia). On 31-Dec-2020, the patient experienced COVID-19 (tested positive for Covid), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), CHEST DISCOMFORT (chest pressure) and COUGH (cough). At the time of the report, COVID-19 (tested positive for Covid), UPPER-AIRWAY COUGH SYNDROME (postnasal drip), MUSCULOSKELETAL STIFFNESS (stiffness), HYPOSMIA (hyposmia), DIARRHOEA (diarrhea), HEADACHE (massive headache), ASTHENIA (weakness), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain) and COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications include Sudafed, Tylenol, zinc , vitamin c, Z-pak and inhaler. No concomitant medications were provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive covid-19; A spontaneous report was received from a healthcare professional, concerning a 41-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed tested positive covid-19.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.  On 10 Jan 2021, the patient experienced tested positive covid-19.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.   At the time of this report, the outcome of event was unknown.; Reporter's Comments: Although a temporal association exist, based on the natural history of COVID-19, the reported event o tested positive covid-19. is assessed as unlikely related with mRNA-1273. Patient most likely had COVID -19 infection as vaccine is not known to cause infection.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021 and was forwarded to Moderna on 19-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts (hives). Concomitant products included VITAMINS NOS for an unknown indication.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced URTICARIA (Hives). On 05-Jan-2021, URTICARIA (Hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included birth control.  Treatment medication included Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: No specific follow-up information recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Rash: "circle 3 inches slightly raised."; Pain: "hurts a bit"; Itchiness. "it itchess"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Rash: "circle 3 inches slightly raised."), VACCINATION SITE PAIN (Pain: "hurts a bit") and VACCINATION SITE PRURITUS (Itchiness. "it itchess") in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Rash: "circle 3 inches slightly raised."), VACCINATION SITE PAIN (Pain: "hurts a bit") and VACCINATION SITE PRURITUS (Itchiness. "it itchess"). At the time of the report, VACCINATION SITE URTICARIA (Rash: "circle 3 inches slightly raised."), VACCINATION SITE PAIN (Pain: "hurts a bit") and VACCINATION SITE PRURITUS (Itchiness. "it itchess") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Feeling abnormal, Headache, Nausea, Vaccination site erythema
Clinical narrative: seeing double; vertigo; nausea; redness around injection site; tenderness around injection site; headache; side of face including ear felt clogged; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged) and DIPLOPIA (seeing double) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoporosis and Cancer. Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRIN 81), ATORVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM CARBONATE AND VITAMIN D), MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), LEVOTHYROXINE, FISH OIL, TOCOPHEROLS MIXED (OMEGA 3 2100), VALSARTAN, ASCORBIC ACID, ZINC (VITAMIN C + ZINC), VITAMIN D3, LEVOFLOXACIN (LEVOMIR) and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache) and FEELING ABNORMAL (side of face including ear felt clogged). On 26-Jan-2021, the patient experienced DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged), DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vertigo
Clinical narrative: seeing double; vertigo; nausea; redness around injection site; tenderness around injection site; headache; side of face including ear felt clogged; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged) and DIPLOPIA (seeing double) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoporosis and Cancer. Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRIN 81), ATORVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM CARBONATE AND VITAMIN D), MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), SITAGLIPTIN (JANUVIA [SITAGLIPTIN]), LEVOTHYROXINE, FISH OIL, TOCOPHEROLS MIXED (OMEGA 3 2100), VALSARTAN, ASCORBIC ACID, ZINC (VITAMIN C + ZINC), VITAMIN D3, LEVOFLOXACIN (LEVOMIR) and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache) and FEELING ABNORMAL (side of face including ear felt clogged). On 26-Jan-2021, the patient experienced DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (redness around injection site), VACCINATION SITE PAIN (tenderness around injection site), HEADACHE (headache), FEELING ABNORMAL (side of face including ear felt clogged), DIPLOPIA (seeing double), VERTIGO (vertigo) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: a green circle appeared on her forearm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (a green circle appeared on her forearm) in a not specif patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN DISCOLOURATION (a green circle appeared on her forearm). At the time of the report, SKIN DISCOLOURATION (a green circle appeared on her forearm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Chills, Diarrhoea, Dry mouth
Clinical narrative: Body aches; Loss of taste; Diarrhea; Difficulty breathing; Dry mouth; Dry nose; Zero energy; Myalgia; Severe headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing) and DRY MOUTH (Dry mouth) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills). At the time of the report, PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant information provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Myalgia, Nasal dryness, Pain
Clinical narrative: Body aches; Loss of taste; Diarrhea; Difficulty breathing; Dry mouth; Dry nose; Zero energy; Myalgia; Severe headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing) and DRY MOUTH (Dry mouth) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills). At the time of the report, PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant information provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Loss of taste; Diarrhea; Difficulty breathing; Dry mouth; Dry nose; Zero energy; Myalgia; Severe headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing) and DRY MOUTH (Dry mouth) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills). At the time of the report, PAIN (Body aches), AGEUSIA (Loss of taste), DIARRHOEA (Diarrhea), DYSPNOEA (Difficulty breathing), DRY MOUTH (Dry mouth), NASAL DRYNESS (Dry nose), ASTHENIA (Zero energy), PYREXIA (Fever), MYALGIA (Myalgia), HEADACHE (Severe headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant information provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site vesicles, Vaccination site warmth
Clinical narrative: arm is red; small blisters; arm a little bit itchy; it is warm to touch; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE VESICLES (small blisters), VACCINATION SITE PRURITUS (arm a little bit itchy) and VACCINATION SITE WARMTH (it is warm to touch) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE VESICLES (small blisters), VACCINATION SITE PRURITUS (arm a little bit itchy) and VACCINATION SITE WARMTH (it is warm to touch). At the time of the report, VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE VESICLES (small blisters), VACCINATION SITE PRURITUS (arm a little bit itchy) and VACCINATION SITE WARMTH (it is warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Heart rate, Insomnia, Myalgia
Clinical narrative: Couldn't move arm; Couldn't sleep in any position but her back; Arm was very sore; got the aching; Just below vaccine,got rash; muscles were hard; muscle swelled up; Red at the site of the vaccine; Joint pain; Muscle pain; Chills; Nausea/ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching) and VACCINATION SITE RASH (Just below vaccine,got rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), CHILLS (Chills) and NAUSEA (Nausea/ready to throw up). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and CHILLS (Chills) was resolving and INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine) and NAUSEA (Nausea/ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Heart rate: 96 Checked in a sitting position for the first time. and 105 Checked for the second time..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication for the event Nausea included Ginger capsule.  Previously administered products included for Smallpox: SMALLPOX VACCINE (Had small pox vaccine when the patient was younger.).   This case was linked to MOD-2021-016218 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up received on 18-Feb-2021 included addition of new events, lab report, treatment medication, and description of the events experienced after the first dose.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Vaccination site erythema, Vaccination site induration
Clinical narrative: Couldn't move arm; Couldn't sleep in any position but her back; Arm was very sore; got the aching; Just below vaccine,got rash; muscles were hard; muscle swelled up; Red at the site of the vaccine; Joint pain; Muscle pain; Chills; Nausea/ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching) and VACCINATION SITE RASH (Just below vaccine,got rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), CHILLS (Chills) and NAUSEA (Nausea/ready to throw up). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and CHILLS (Chills) was resolving and INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine) and NAUSEA (Nausea/ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Heart rate: 96 Checked in a sitting position for the first time. and 105 Checked for the second time..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication for the event Nausea included Ginger capsule.  Previously administered products included for Smallpox: SMALLPOX VACCINE (Had small pox vaccine when the patient was younger.).   This case was linked to MOD-2021-016218 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up received on 18-Feb-2021 included addition of new events, lab report, treatment medication, and description of the events experienced after the first dose.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site rash, Vaccination site swelling
Clinical narrative: Couldn't move arm; Couldn't sleep in any position but her back; Arm was very sore; got the aching; Just below vaccine,got rash; muscles were hard; muscle swelled up; Red at the site of the vaccine; Joint pain; Muscle pain; Chills; Nausea/ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching) and VACCINATION SITE RASH (Just below vaccine,got rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), CHILLS (Chills) and NAUSEA (Nausea/ready to throw up). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Couldn't move arm), VACCINATION SITE RASH (Just below vaccine,got rash), VACCINATION SITE INDURATION (muscles were hard), VACCINATION SITE SWELLING (muscle swelled up), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and CHILLS (Chills) was resolving and INSOMNIA (Couldn't sleep in any position but her back), PAIN IN EXTREMITY (Arm was very sore), PAIN (got the aching), VACCINATION SITE ERYTHEMA (Red at the site of the vaccine) and NAUSEA (Nausea/ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Heart rate: 96 Checked in a sitting position for the first time. and 105 Checked for the second time..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication for the event Nausea included Ginger capsule.  Previously administered products included for Smallpox: SMALLPOX VACCINE (Had small pox vaccine when the patient was younger.).   This case was linked to MOD-2021-016218 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Follow-up received on 18-Feb-2021 included addition of new events, lab report, treatment medication, and description of the events experienced after the first dose.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Swelling, Vertigo
Clinical narrative: vertigo; fatigue; swelling; pain; This spontaneous case was reported by a consumer and describes the occurrence of   in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details: The patient self administered Ibuprofen TID consulting a HCP on 19jan2021.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site swelling
Clinical narrative: swelling at injection site; slight nausea; red and swell at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (red and swell at injection site) and NAUSEA (slight nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red and swell at injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at injection site) and NAUSEA (slight nausea). At the time of the report, VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (red and swell at injection site) and NAUSEA (slight nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a health care professional and describes the occurrence of URTICARIA (hives) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZOA) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced URTICARIA (hives). On 18-Jan-2021, URTICARIA (hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: Non significant follow-up. NNI
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site erythema, Vaccination site pain
Clinical narrative: soreness at injection site; Shot site has redness; Shot site has tenderness, slight pain/ Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (soreness at injection site), VACCINATION SITE ERYTHEMA (Shot site has redness) and VACCINATION SITE PAIN (Shot site has tenderness, slight pain/ Soreness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Shot site has redness) and VACCINATION SITE PAIN (Shot site has tenderness, slight pain/ Soreness at injection site). On 18-Jan-2021, the patient experienced TENDERNESS (soreness at injection site). At the time of the report, TENDERNESS (soreness at injection site), VACCINATION SITE ERYTHEMA (Shot site has redness) and VACCINATION SITE PAIN (Shot site has tenderness, slight pain/ Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pyrexia, Tachycardia
Clinical narrative: Tachycardia; Tingling in the arm and head; fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an occupational therapist (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Tachycardia), PARAESTHESIA (Tingling in the arm and head) and PYREXIA (fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1016) for COVID-19 vaccination.     Concurrent medical conditions included Premature ventricular contractions and Seasonal allergy.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced TACHYCARDIA (Tachycardia), PARAESTHESIA (Tingling in the arm and head) and PYREXIA (fever). At the time of the report, TACHYCARDIA (Tachycardia), PARAESTHESIA (Tingling in the arm and head) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for these events included Benadryl at night and Diltiazemer 120 mg per day.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: right hand swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (right hand swelling) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PERIPHERAL SWELLING (right hand swelling). On 19-Jan-2021, PERIPHERAL SWELLING (right hand swelling) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Mobility decreased
Clinical narrative: breathing this hot, scratchy air into my throat; no appetite; couldn't lift her arm; Fatigue; chills; Headache; Fever; This spontaneous case was reported by a patient and describes the occurrence of RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attack, Airways obstruction, Chills, Fever, Headache, Pain, Appetite absent, Fatigue and Arm spasticity.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue), CHILLS (chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue), CHILLS (chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatments reported included use of unspecified antihistamines.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiration abnormal
Clinical narrative: breathing this hot, scratchy air into my throat; no appetite; couldn't lift her arm; Fatigue; chills; Headache; Fever; This spontaneous case was reported by a patient and describes the occurrence of RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue) and CHILLS (chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Panic attack, Airways obstruction, Chills, Fever, Headache, Pain, Appetite absent, Fatigue and Arm spasticity.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue), CHILLS (chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, RESPIRATION ABNORMAL (breathing this hot, scratchy air into my throat), DECREASED APPETITE (no appetite), MOBILITY DECREASED (couldn't lift her arm), FATIGUE (Fatigue), CHILLS (chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatments reported included use of unspecified antihistamines.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: having reactions to the vaccine; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (having reactions to the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (having reactions to the vaccine). At the time of the report, VACCINATION COMPLICATION (having reactions to the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: 2-3" raised red, raised rash at injection site; 2-3" raised red, raised rash at injection site; Itchy injection site; sore injection site/arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore injection site/arm), VACCINATION SITE RASH (2-3" raised red, raised rash at injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE ERYTHEMA (2-3" raised red, raised rash at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K2VA) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore injection site/arm). On 16-Jan-2021, the patient experienced VACCINATION SITE RASH (2-3" raised red, raised rash at injection site) and VACCINATION SITE PRURITUS (Itchy injection site). On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (2-3" raised red, raised rash at injection site). On 11-Jan-2021, VACCINATION SITE PAIN (sore injection site/arm) had resolved. At the time of the report, VACCINATION SITE RASH (2-3" raised red, raised rash at injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE ERYTHEMA (2-3" raised red, raised rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: The injection site became painful, itchy, swollen, and increased in redness; Pain, swelling, and redness immediately below the site of injection; Pain, swelling, and redness immediately below the site of injection; Pain, swelling, and redness immediately below the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain, swelling, and redness immediately below the site of injection), VACCINATION SITE SWELLING (Pain, swelling, and redness immediately below the site of injection), VACCINATION SITE ERYTHEMA (Pain, swelling, and redness immediately below the site of injection) and VACCINATION SITE PRURITUS (The injection site became painful, itchy, swollen, and increased in redness) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain, swelling, and redness immediately below the site of injection), VACCINATION SITE SWELLING (Pain, swelling, and redness immediately below the site of injection) and VACCINATION SITE ERYTHEMA (Pain, swelling, and redness immediately below the site of injection). On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (The injection site became painful, itchy, swollen, and increased in redness). On 12-Jan-2021, VACCINATION SITE PAIN (Pain, swelling, and redness immediately below the site of injection), VACCINATION SITE SWELLING (Pain, swelling, and redness immediately below the site of injection) and VACCINATION SITE ERYTHEMA (Pain, swelling, and redness immediately below the site of injection) had resolved. At the time of the report, VACCINATION SITE PRURITUS (The injection site became painful, itchy, swollen, and increased in redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was treated with antibiotics and steroids.   Reporter did not allow further contact
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: received the Covid-19 vaccination Friday. 6 hours later it started bothering him.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (received the Covid-19 vaccination Friday. 6 hours later it started bothering him.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION COMPLICATION (received the Covid-19 vaccination Friday. 6 hours later it started bothering him.). At the time of the report, VACCINATION COMPLICATION (received the Covid-19 vaccination Friday. 6 hours later it started bothering him.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact